These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20453222)

  • 21. Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma.
    Maekawa N; Konnai S; Okagawa T; Nishimori A; Ikebuchi R; Izumi Y; Takagi S; Kagawa Y; Nakajima C; Suzuki Y; Kato Y; Murata S; Ohashi K
    PLoS One; 2016; 11(6):e0157176. PubMed ID: 27276060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FoxP3, CTLA-4, and IDO in Canine Melanocytic Tumors.
    Porcellato I; Brachelente C; Cappelli K; Menchetti L; Silvestri S; Sforna M; Mecocci S; Iussich S; Leonardi L; Mechelli L
    Vet Pathol; 2021 Jan; 58(1):42-52. PubMed ID: 33021155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective accumulation of differentiated FOXP3(+) CD4 (+) T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood.
    Jandus C; Bioley G; Speiser DE; Romero P
    Cancer Immunol Immunother; 2008 Dec; 57(12):1795-805. PubMed ID: 18414854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer immunology and canine malignant melanoma: A comparative review.
    Atherton MJ; Morris JS; McDermott MR; Lichty BD
    Vet Immunol Immunopathol; 2016 Jan; 169():15-26. PubMed ID: 26827834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of immunoregulatory T cells in different stages of breast cancer patients.
    Abo-Elenein A; Elgohary SE; Hashish A; El-Halaby E
    Egypt J Immunol; 2008; 15(2):145-52. PubMed ID: 20306697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
    Yu Y; Huang R; Zong X; He X; Mo W
    BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?
    Hmida NB; Ben Ahmed M; Moussa A; Rejeb MB; Said Y; Kourda N; Meresse B; Abdeladhim M; Louzir H; Cerf-Bensussan N
    Am J Gastroenterol; 2012 Apr; 107(4):604-11. PubMed ID: 22108452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating CD4(+)CD25(+)Foxp3(+) T regulatory cell levels in an experimental model of canine atopic dermatitis.
    Rostaher A; Fischer NM; Urwyler A; Favrot C
    Vet Dermatol; 2018 Dec; 29(6):511-e171. PubMed ID: 30318823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A combination of electrochemotherapy, gene electrotransfer of plasmid encoding canine IL-12 and cytoreductive surgery in the treatment of canine oral malignant melanoma.
    Milevoj N; Tratar UL; Nemec A; Brožič A; Žnidar K; Serša G; Čemažar M; Tozon N
    Res Vet Sci; 2019 Feb; 122():40-49. PubMed ID: 30453179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
    Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
    Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase of regulatory T cells in the peripheral blood of dogs with metastatic tumors.
    Horiuchi Y; Tominaga M; Ichikawa M; Yamashita M; Jikumaru Y; Nariai Y; Nakajima Y; Kuwabara M; Yukawa M
    Microbiol Immunol; 2009 Aug; 53(8):468-74. PubMed ID: 19659931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation.
    Sánchez J; Ramirez GA; Buendia AJ; Vilafranca M; Martinez CM; Altimira J; Navarro JA
    Vet Pathol; 2007 Sep; 44(5):676-82. PubMed ID: 17846240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in Immunogenicity during the Development of Urinary Bladder Cancer: A Preliminary Study.
    Jóźwicki W; Brożyna AA; Siekiera J; Slominski AT
    Int J Mol Sci; 2016 Feb; 17(3):285. PubMed ID: 26927070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma.
    Al-Qahtani D; Anil S; Rajendran R
    J Oral Pathol Med; 2011 Sep; 40(8):636-42. PubMed ID: 21352381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory T cells, Cytotoxic T lymphocytes and a T(H)1 cytokine profile in dogs naturally infected by Leishmania infantum.
    Cortese L; Annunziatella M; Palatucci AT; Rubino V; Piantedosi D; Di Loria A; Ruggiero G; Ciaramella P; Terrazzano G
    Res Vet Sci; 2013 Dec; 95(3):942-9. PubMed ID: 24079840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-infiltrating regulatory T cells are positively correlated with angiogenic status in renal cell carcinoma.
    Ning H; Shao QQ; Ding KJ; Gao DX; Lu QL; Cao QW; Niu ZH; Fu Q; Zhang CH; Qu X; Lü JJ
    Chin Med J (Engl); 2012 Jun; 125(12):2120-5. PubMed ID: 22884140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profiling of plasma metabolites in canine oral melanoma using gas chromatography-mass spectrometry.
    Kawabe M; Baba Y; Tamai R; Yamamoto R; Komori M; Mori T; Takenaka S
    J Vet Med Sci; 2015 Aug; 77(8):1025-8. PubMed ID: 25843037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
    Kurose K; Ohue Y; Sato E; Yamauchi A; Eikawa S; Isobe M; Nishio Y; Uenaka A; Oka M; Nakayama E
    J Thorac Oncol; 2015 Jan; 10(1):74-83. PubMed ID: 25325779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Standardized approach for evaluating tumor infiltrating lymphocytes in canine mammary carcinoma: Spatial distribution and score as relevant features of tumor malignancy.
    Muscatello LV; Avallone G; Brunetti B; Bacci B; Foschini MP; Sarli G
    Vet J; 2022; 283-284():105833. PubMed ID: 35489672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.